InvestorsHub Logo

Dell_Griffith

09/08/20 8:27 AM

#200740 RE: JoTu #200738

arthrex displaying on its website a comparison table outlining the benefits of bmg over nitinol is a very positive indication of future use.



Yes, good call. Looks that way and the litigation pushed out Kang with LQMT waiting on the sidelines to play the game.

Bruce looked very presidential in that email exchange with Arthrex. He’s a VERY crafty guy! BRILLIANT, I might add!

BRUCE BROMAGE 4 PRESIDENT!

P.S. Great call, sir. That looks like the “targeted market.” Can’t rule out CE, but medical is big margins, too.

The Paraclete

09/08/20 8:34 AM

#200743 RE: JoTu #200738

That table came from a scientific paper I read... not from Arthrex. I should have made that clear.

I used to insert Nitinol Intravascular stents, so I am familiar with the pros and cons of that material. BMGs may not work for such stents, but metallic glass would be superior to the Nitinol products used by Arthrex.

Arthrex and ConMed will advertise their new devices made with liquidmetal, but they might want to wait until they have a sufficient supply in their inventory before they begin their sales push. I’ll keep an eye out.

jrs5

09/08/20 11:17 AM

#200758 RE: JoTu #200738

Can you post the link please?